This Is MS Multiple Sclerosis Community: Knowledge & Support

Welcome to the world's leading forum on Multiple Sclerosis research, support, and knowledge. For over 10 years, This is MS has provided an unbiased community dedicated to Multiple Sclerosis patients, caregivers, and affected loved ones.
It is currently Thu Jun 20, 2013 1:24 am


All times are UTC - 8 hours [ DST ]




Post new topic Reply to topic  [ 4 posts ] 
Author Message
PostPosted: Fri Nov 26, 2010 2:06 am 
Offline
Family Elder
User avatar

Joined: Wed Oct 14, 2009 3:00 pm
Posts: 1713
Image

Trophos SA a clinical stage pharmaceutical company developing innovative therapeutics from discovery to clinical validation for indications with under-served needs in neurology and cardiology, announced that Trophos and partners in the MS-Repair consortium delivered an oral presentation detailing Trophos' novel approach in multiple sclerosis (MS) at the recent Society for Neuroscience (SfN) Meeting. The data presented demonstrate that olesoxime, Trophos' lead compound, is a promising candidate for neuroaxonal repair and remyelination in white matter diseases, notably multiple sclerosis. The MS-Repair project is supported by the French Agence Nationale pour la Recherche (ANR).... Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1397

_________________
The Multiple Sclerosis Resource Centre

Squiffy's House of Fun - Laughter for Multiple Sclerosis


Top
 Profile  
 
 Post subject:
PostPosted: Sat Nov 27, 2010 3:00 pm 
Offline
Family Elder
User avatar

Joined: Sat Oct 20, 2007 3:00 pm
Posts: 946
Location: The United Kingdom
Oh, this is good news. In a long term perspective sort of way.


Top
 Profile  
 
 Post subject:
PostPosted: Sun Nov 28, 2010 2:19 pm 
Offline
Family Elder
User avatar

Joined: Sat Oct 20, 2007 3:00 pm
Posts: 946
Location: The United Kingdom
By the way, it needs an accent over the 'e,' It should be Olésoxime.


Top
 Profile  
 
 Post subject:
PostPosted: Sat Apr 23, 2011 1:27 pm 
Offline
Family Elder
User avatar

Joined: Sat Oct 20, 2007 3:00 pm
Posts: 946
Location: The United Kingdom
>Another press release..<


Top
 Profile  
 
Display posts from previous:  Sort by  
Post new topic Reply to topic  [ 4 posts ] 

All times are UTC - 8 hours [ DST ]


Related topics
 Topics   Author   Replies   Views   Last post 
There are no new unread posts for this topic. Critical MS data presented by Mount Sinai researchers

squiffy2

1

706

Fri Apr 15, 2011 8:45 am

Daisy3 View the latest post

There are no new unread posts for this topic. New antibody approach

TwistedHelix

0

756

Thu May 17, 2007 11:50 am

TwistedHelix View the latest post

There are no new unread posts for this topic. The Liberation Treatment: A whole new approach to MS

[ Go to pageGo to page: 1, 2 ]

Alica

28

3420

Sun Nov 29, 2009 10:54 am

amc View the latest post

There are no new unread posts for this topic. Diet and Supplements in MS: A Reasonable Approach

Melody

6

1815

Mon Jun 05, 2006 6:02 am

jimmylegs View the latest post

There are no new unread posts for this topic. Proteomics, a new approach to autoimmune diseases

squiffy2

0

756

Fri Jun 03, 2011 3:35 am

squiffy2 View the latest post

 


Who is online

Users browsing this forum: No registered users


You cannot post new topics in this forum
You cannot reply to topics in this forum
You cannot edit your posts in this forum
You cannot delete your posts in this forum

Search for:
Jump to:  


News News Site map Site map SitemapIndex SitemapIndex RSS Feed RSS Feed Channel list Channel list
Read hundreds of personal Multiple Sclerosis stories on Experience Project. Experience Project is an anonymous community where people connect through their life experiences, made by the same people who built This is MS. With over 30 million personal stories about every possible life experience, you can quickly find people like you!


Interesting: Secret Confessions | Dream Meanings | Ask Questions, Get Answers

Advertise on the premier multiple sclerosis forum